• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Carnosic Acid

Carnosic Acid

Product ID C0265
Cas No. 3650-09-7
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $102.00 In stock
25 mg $183.60 In stock
50 mg $310.20 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Carnosic acid is a diterpene found in Rosmarinus that exhibits antioxidative, anti-inflammatory, neuroprotective, cognition enhancing, and anticancer chemotherapeutic activities. Carnosic acid inhibits growth of colon adenocarcinoma cells and decreases tumor number in vivo by downregulating expression of Bcl-xl and cyclin D1 and inducing cell cycle arrest and apoptosis. Carnosic acid also induces autophagy and inhibits Akt/mTOR signaling in hepatoma cells. In animal models of Alzheimer’s disease, carnosic acid ameliorates amyloid β (Aβ)-induced spatial memory and learning deficits. In other animal models, this compound decreases isoproterenol-induced increases in troponin I, creatine kinase, lactate dehydrogenase, SGOT, and SGPT and upregulates activity of phase II enzymes. Additionally, carnosic acid decreases TNF-α-induced activation of ERK, JNK, and IKK and expression of mTOR, eIF4E, and IL-6 in vitro.

Product Info

Cas No.

3650-09-7

Purity

≥98%

Formula

C20H28O4

Formula Wt.

332.43

IUPAC Name

(4aR,10aS)-5,6-dihydroxy-1,1-dimethyl-7-propan-2-yl-2,3,4,9,10, 10a-hexahydrophenanthrene-4a-carboxylic acid

Synonym

Salvin

Melting Point

193-199°C

Solubility

Slightly soluble in water. Soluble in DMSO, ethanol.

Appearance

Light Yellow Powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

C0265 MSDS PDF

Info Sheet

C0265 Info Sheet PDF

References

Kim YJ, Kim JS, Seo YR, et al. Carnosic acid suppresses colon tumor formation in association with anti-adipogenic activity. Mol Nutr Food Res. 2014 Sep 9. [Epub ahead of print]. PMID: 25204550.

Gao Q, Liu H, Yao Y, et al. Carnosic acid induces autophagic cell death through inhibition of the Akt/mTOR pathway in human hepatoma cells. J Appl Toxicol. 2014 Sep 1. [Epub ahead of print]. PMID: 25178877.

Sahu BD, Putcha UK, Kuncha M, et al. Carnosic acid promotes myocardial antioxidant response and prevents isoproterenol-induced myocardial oxidative stress and apoptosis in mice. Mol Cell Biochem. 2014 Sep;394(1-2):163-76. PMID: 24903830.

Tsai CW, Liu KL, Lin YR, et al. The mechanisms of carnosic acid attenuates tumor necrosis factor-α-mediated inflammation and insulin resistance in 3T3-L1 adipocytes. Mol Nutr Food Res. 2014 Apr;58(4):654-64. PMID: 24668853.

Rasoolijazi H, Azad N, Joghataei MT, et al. The protective role of carnosic acid against beta-amyloid toxicity in rats. ScientificWorldJournal. 2013 Oct 24;2013:917082. PMID: 24363627.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • M568268

    Mogroside IV

    Triterpenoid

    ≥98%
  • F4681

    Flumazenil

    GABA-A antagonist.

    ≥98%
  • M1626

    Megestrol Acetate

    Synthetic progestogen, orexigenic.

    ≥98%
  • M3353

    Minocycline Hydrochloride

    Tetracycline; protein translation inhibitor, MM...

    ≥98%
  • H9803

    Hyaluronic Acid Sodium (0.2 -5 kDA)

    Glycosaminoglycan

  • M185770

    5-Methyltetrahydrofolic Acid

    Folic acid derivative

    ≥98%
  • J6400

    (+)-JQ-1

    Triazolothienodiazepine; BRD inhibitor.

    ≥99%
  • E7556

    Etodolac

    NSAID; TRPA1 agonist, COX-2 inhibitor.

    ≥98%
  • E9418

    Exendin 3 (9-39)

    Peptide, GLP-1 analog found in Heloderma; GLP-1...

    ≥95%
  • I4962

    Isoimperatorin

    Furocoumarin; COX-2 inhibitor.

    ≥98%
  • R7680

    Recombinant M. Tuberculosis Antigen TB 38+6+10

    Tuberculosis antigen

  • L1817

    Leflunomide

    AhR agonist, dihydroorotate dehydrogenase inhib...

    ≥98%
  • G8225

    Guggulsterone

    Steroid found in myrrh; FXR antagonist.

    ≥98%
  • C0147

    Calcium Folinate Pentahydrate

    Folate source co-administered with methotrexate...

    ≥95%
  • I5210

    INCB018424

    JAK1/2 inhibitor.

    ≥98%
  • A985132

    AZD-8186

    Selective inhibitor of PI3Kβ and PI3Kδ.

    ≥99%
  • M0374

    Masitinib

    PDGFR and c-Kit inhibitor.

    ≥99%
  • R0110

    Ractopamine Hydrochloride

    β1/2-adrenergic agonist.

    ≥97%
  • T1968

    Terpinen-4-ol

    Monoterpene found in various plant sources.

    ≥98%
  • L8377

    Luteolin

    Flavonoid found in various plant sources; DAT a...

    ≥95%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only